Dendritic cell subsets as vectors and targets for improved cancer therapy

Keyphrases

• Cancer Therapy 100%
• Dendritic Cell Subsets 100%
• Metastatic Disease 66%
• Clinical Efficacy 66%
• Treg 66%
• Tumor 33%
• T Cells 33%
• Dendritic Cells 33%
• Tumor Regression 33%
• Monotherapy 33%
• Adaptive Immunity 33%
• Adaptive Immune Response 33%
• Regulatory T Cells 33%
• Cell Systems 33%
• Drug Target 33%
• Activation Mechanism 33%
• Dendritic Cell Vaccine 33%
• Immune System 33%
• Effector Cells 33%
• Immunotherapy Trials 33%
• Cancer Vaccine 33%
• Myeloid-derived Suppressor Cells 33%
• Immunosuppressive Microenvironment 33%
• Inflammatory Subtype 33%
• Dendritic Cell Activation 33%
• T Regulatory 33%
• Active Immunization 33%
• Tumor Environment 33%
• Improved Strategies 33%

Immunology and Microbiology

• Regulatory T Cell 100%
• Dendritic Cell Subset 100%
• Dendritic Cell 66%
• Adaptive Immune System 66%
• T Cell 33%
• Effector Cell 33%
• Cell Activation 33%
• Immunosuppressive Drug 33%
• Dendritic Cell Vaccine 33%
• Suppressor Cell 33%
• Drug Targeting 33%
• Tumor Vaccine 33%
• Immune System 33%
• Active Immunotherapy 33%